DOC vs EPR
Healthpeak Properties vs EPR Properties — AI-powered side-by-side comparison
DOC
Healthpeak Properties
64
Buy
VS
EPR
EPR Properties
71
Buy
| Metric | DOC | EPR |
|---|
| AI Score |
64
|
71
|
| Price |
$20.50
|
$59.81
|
| P/E Ratio |
58.60×
|
19.04×
|
| ROE |
1.0%
|
11.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
2.5%
|
69.6%
|
| Debt / Equity |
1.32×
|
1.53×
|
| Dividend Yield |
5.9%
|
6.0%
|
| RSI (14) |
31.1
|
36.2
|
| Beta |
0.991
|
1.019
|
| Expected Upside |
+1.6%
|
+1.0%
|
AI Committee View
Current Innellis committee reasoning for DOC versus EPR.
EPR leads by 7 points.
EPR scores 71/100 (Buy) versus DOC at 64/100 (Buy).
DOC Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
- Price trading below the lower Bollinger Band -- stretched to the downside — Technical
EPR Committee View
100% agreement
4 analysts
The primary driver is 3 consecutive earnings beats -- consistent execution. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- 3 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical